One patient returned to the hospital just three months after surgery for Dysplasia Epiphysealis Hemimelica. The condition came back, and the patient faced increased pain, limping, and significant ankle stiffness. These symptoms were much worse than when they first arrived at the clinic. Doctors looked at the tissue under a microscope and found immature fibrocartilaginous tissue and nodular proliferation of collagenous fibrous tissue. They also saw cartilage fragments and a foreign-body granulomatous reaction. These findings suggest the surgery did not fully remove the problem area. The patient's age and how much of the tissue was left behind likely played a big role in the failure. This single story does not prove what happens for everyone, but it warns doctors to be very careful. The team suggests a new follow-up plan to try and stop this recurrence from happening again. Without strict monitoring, patients might face the same painful return of symptoms too soon after healing.
Case Report and Review of Recurrent Dysplasia Epiphysealis Hemimelica After SurgeryOne patient's surgery failed at three months, showing how age and incomplete removal cause recurrence
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This article is a case report combined with a review of the literature on Dysplasia Epiphysealis Hemimelica (DEH), focusing on recurrence after surgical intervention. The authors present a single patient who experienced recurrence of DEH 3 months following initial surgery, with symptoms including increased pain, limping, and significant ankle stiffness compared to the initial presentation. Histopathological examination of the recurrent lesion revealed immature fibrocartilaginous tissue, nodular proliferation of collagenous fibrous tissue, cartilage fragments, and foreign-body granulomatous reaction.
The authors note that recurrence in DEH is closely linked to incomplete surgical excision and the patient's age. Based on this single case and review, they propose a postoperative follow-up protocol to mitigate the risk of recurrence. However, the evidence is limited by the nature of a single case report, and generalizability beyond this case is not possible.
No adverse events or safety data were reported. The practice relevance is limited to suggesting a follow-up protocol, but clinicians should recognize that these findings are derived from a single case and literature review, not from a controlled study.
View Original Abstract ↓
Evaluating the Efficacy of Traditional Chinese Medicine Decoctions for Rheumatoid Arthritis Management
Traditional Chinese medicine decoctions may improve rheumatoid arthritis symptoms
Related in Rheumatology
From Other Specialties
